These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8749529

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H, Shiratori K, Yamamoto M, Takasaki K, Nakano M.
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [Abstract] [Full Text] [Related]

  • 23. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T, Wakasa K, Shutou T, Hai S, Kubo S, Hirohashi K, Umeshita K, Monden M.
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Cholangiocellular carcinoma associated with liver cirrhosis].
    Suzuki Y, Aoyagi Y, Naitoh A, Isokawa O.
    Ryoikibetsu Shokogun Shirizu; 1995 Mar; (7):357-9. PubMed ID: 8749494
    [No Abstract] [Full Text] [Related]

  • 26. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL, Das KM, Fogt F, Burke M, Murakata LA.
    Oncol Rep; 2002 Mar; 9(6):1369-72. PubMed ID: 12375050
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A case of metachronous cholangiocellular and hepatocellular carcinoma with good prognosis.
    Kosone T, Takagi H, Hamada T, Kakizaki S, Takehara K, Ohwada S, Mori M.
    Hepatogastroenterology; 2005 Mar; 52(64):1228-32. PubMed ID: 16001668
    [Abstract] [Full Text] [Related]

  • 30. Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma.
    Saboo SS, Krajewski KM, Jagannathan JP, O'Regan KN, Odze R, Ramaiya N, Wolpin BM.
    Cancer Imaging; 2011 Mar 31; 11(1):37-41. PubMed ID: 21507775
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers.
    Man XB, Tang L, Zhang BH, Li SJ, Qiu XH, Wu MC, Wang HY.
    Liver Int; 2005 Oct 31; 25(5):962-6. PubMed ID: 16162153
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MR imaging of the liver. Primary malignant neoplasms in the adult.
    Buetow PC, Midkiff RB.
    Magn Reson Imaging Clin N Am; 1997 May 31; 5(2):289-318. PubMed ID: 9113676
    [Abstract] [Full Text] [Related]

  • 37. [Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
    Niinobu T, Shibata T, Fukushima Y, Kitada M, Tukahara Y, Hata S, Ikeda K, Hayashida H, Fuzita J, Takahashi Y, Nakamura T, Suzuki R, Shimano T, Takami M, Ishida T.
    Gan To Kagaku Ryoho; 2000 Oct 31; 27(12):1931-5. PubMed ID: 11086448
    [Abstract] [Full Text] [Related]

  • 38. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    Ann Surg Oncol; 2009 Mar 31; 16(3):623-9. PubMed ID: 19130133
    [Abstract] [Full Text] [Related]

  • 39. [A case of combined liver cell and bile duct carcinoma detected 6 years after interferon therapy for chronic hepatitis C, in spite of showing complete response].
    Morizono S, Fukutomi M, Yokota M, Iguchi H, Funakoshi A, Wakasugi H, Ikeda Y, Hachitanda Y.
    Nihon Shokakibyo Gakkai Zasshi; 2002 May 31; 99(5):505-10. PubMed ID: 12048895
    [No Abstract] [Full Text] [Related]

  • 40. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y, Lee SK, Kim JS, Ro JY, Yu E.
    Mod Pathol; 2002 Oct 31; 15(10):1096-101. PubMed ID: 12379757
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.